Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Lrig1 could be a marker for advanced sebaceous carcinoma.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Estrogen therapy can reduce skin aging but has cancer risks.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.